mRNA vaccines have been in development since 1990. It is not a new technology. One of its inherent advantages over traditional vaccines, is the speed the vaccine can be designed and produced, hence the speed in which it could be deployed, especially as vast resources ($ and therefore staff and plant) could be utilized in response to COVID.